Support: 888-992-3836 Home NewsWire Subscriptions
InvestorsHub Logo
Login/Register
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Marker Therapeutics Inc (MRKR)
  7. News

MRKR

Marker Therapeutics Inc
2.64
-0.06 (-2.22%)
Upgrade to Real-Time
Company Name Stock Ticker Symbol Market Type
Marker Therapeutics Inc MRKR NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
Upgrade Icon
-0.06 -2.22% 2.64 16:02:01
Open Price Low Price High Price Close Price Prev Close
2.79 2.52 2.84 2.64 2.70
more quote information »

Recent News

Date Time Source Heading
2/02/20239:58IHNWFeaturedGoldshore Intersects 9.46 g/t Au over 7.45m in the Southwest Zone Widths of Mineralized System Expanded Significantly.
2/02/20239:30IHNWFeaturedHempacco and Snoop Dogg Create Joint Venture to Launch Consumer Goods Powerhouse of Hemp and Hemp-Derived Products
2/02/20237:03IHNWFeaturedAmerican Green (OTC:ERBB) Receives Equipment Lease Funding for its 40K s.f. Cypress Chill Cannabis Grow
1/26/202316:17EDGARCurrent Report Filing (8-k)
1/03/202309:01EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
1/03/202306:05EDGARNotice of Effectiveness (effect)
12/23/202209:01EDGARSecurities Registration Statement (s-1)
12/13/202207:00GLOBEMarker Therapeutics and Lincoln Park Capital Enter into a..
11/22/202207:16EDGARCurrent Report Filing (8-k)
11/22/202207:00GLOBEMarker Therapeutics Announces FDA Clearance of IND for..
11/10/202216:20EDGARCurrent Report Filing (8-k)
11/10/202216:07EDGARQuarterly Report (10-q)
11/10/202216:05GLOBEMarker Therapeutics Reports Q3 2022 Operating and Financial..
10/20/202216:32EDGARCurrent Report Filing (8-k)
9/27/202208:46EDGARCurrent Report Filing (8-k)
9/13/202209:17EDGARCurrent Report Filing (8-k)
9/13/202207:00GLOBEMarker Therapeutics Awarded $2 Million Grant from U.S. FDA..
9/08/202207:00GLOBEMarker Therapeutics to Participate in Cantor Fitzgerald Cell..
8/19/202208:31EDGARCurrent Report Filing (8-k)
8/11/202217:11EDGARSecurities Registration: Employee Benefit Plan (s-8)
8/11/202216:39EDGARQuarterly Report (10-q)
8/11/202216:22GLOBEMarker Therapeutics Reports Q2 2022 Operating and Financial..
8/05/202212:04DJNMarker Therapeutics Shares Climb Over 50% After FDA Approves..
8/04/202218:28DJNMarker Therapeutics Shares Double After Hours, FDA Approves..
8/04/202216:51EDGARCurrent Report Filing (8-k)
8/04/202216:37GLOBEMarker Therapeutics Announces FDA Clearance of IND for..
5/27/202216:20EDGARCurrent Report Filing (8-k)
5/26/202216:23EDGARStatement of Changes in Beneficial Ownership (4)
5/26/202216:22EDGARStatement of Changes in Beneficial Ownership (4)
5/26/202216:22EDGARStatement of Changes in Beneficial Ownership (4)
5/26/202216:21EDGARStatement of Changes in Beneficial Ownership (4)
5/13/202207:12EDGARCurrent Report Filing (8-k)
5/13/202207:00GLOBEMarker Therapeutics Reports Q1 2022 Operating and Financial..
5/04/202210:30GLOBEMarker Therapeutics to Present Four Posters on its T..
4/26/202207:25EDGARCurrent Report Filing (8-k)
4/26/202207:00GLOBEMarker Therapeutics Announces Entry into Services Agreement..
4/15/202216:32EDGARProxy Statement (definitive) (def 14a)
4/06/202216:12EDGARProxy Statement - Notice of Shareholders Meeting..
3/18/202217:23EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
3/18/202206:02EDGARCurrent Report Filing (8-k)
3/17/202218:05SEEKMarker Therapeutics GAAP EPS of -$0.55 beats by $0.02,..
3/17/202217:45GLOBEMarker Therapeutics Reports Fiscal Year 2021 Operating and..
3/07/202216:05GLOBEMarker Therapeutics to Present at Two Upcoming March..
2/22/202217:15EDGARStatement of Changes in Beneficial Ownership (4)
2/22/202217:10EDGARStatement of Changes in Beneficial Ownership (4)
2/22/202217:10EDGARStatement of Changes in Beneficial Ownership (4)
2/22/202217:09EDGARStatement of Changes in Beneficial Ownership (4)
2/22/202217:06EDGARStatement of Changes in Beneficial Ownership (4)
2/22/202217:04EDGARStatement of Changes in Beneficial Ownership (4)
2/22/202217:04EDGARStatement of Changes in Beneficial Ownership (4)
2/18/202216:06EDGARCurrent Report Filing (8-k)
2/16/202216:33EDGARCurrent Report Filing (8-k)
2/16/202216:30GLOBEMarker Therapeutics Announces Clinical Program Updates and..